New USP proposal for updating identity checks in U.S. Pharmacopeia
Recommendation

Thursday, 3 September 2026 9 .00 - 17.00 h
Establishment, Use and Maintenance of Analytical Reference Substances
In the Pharmacopeial Forum 41(2), an article entitled 'Stimuli to the Revision Process' on the modernisation of the general chapter on identity checks <191> has been published in USP/NF. The same issue of PF 41(2) also contains the proposal to revise this existing general chapter <191>.
The chapter <191> treats the identification of ions or counterions in active substances that exist as salt compounds. The plan is to replace the existing flame test from <191> since it is not particularly meaningful. In future, selecting the options for identity checks in chapter <191> will be more flexible. Users will be able to apply other methods as long as they have been properly validated.
The following instrumental methods are being considered:
- X-ray fluorescence (XRF)
- Atom spectrometry (AA)
- ICP-OES
- ICP-MS
- IR
- Raman
- Ion chromatography
Other methods can also be used. However, the prerequisite here is that the user must document the specificity of a method as part of the validation.
For detailed information on the USP proposal, please see the USP website of Pharmacopeial Forum (PF).
Source: USP
Related GMP News
01.07.2026Several FDA Warning Letters and Untitled Letters on Asbestos Testing of Talc in OTC Drug Products
24.06.2026Analytical Quality Group Developments January through April 2026
17.06.2026BioPhorum Publishes a Roadmap for QC Sample Test Execution
03.06.2026EMA Provides an Outlook on the Product-Specific Bioequivalence Guidelines Expected in 2026
03.06.2026FDA Warning Letter: Missing Method Validation - From a QC Topic to a Market-Access Problem
28.05.2026WHO Working Document on Bioequivalence open for Public Consultation


